These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Prostate-specific antigen stimulates osteoprotegerin production and inhibits receptor activator of nuclear factor-kappaB ligand expression by human osteoblasts. Yonou H; Horiguchi Y; Ohno Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M Prostate; 2007 Jun; 67(8):840-8. PubMed ID: 17394194 [TBL] [Abstract][Full Text] [Related]
5. Inductive effects of dexamethasone on the mineralization and the osteoblastic gene expressions in mature osteoblast-like ROS17/2.8 cells. Mikami Y; Omoteyama K; Kato S; Takagi M Biochem Biophys Res Commun; 2007 Oct; 362(2):368-73. PubMed ID: 17707772 [TBL] [Abstract][Full Text] [Related]
6. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts. Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635 [TBL] [Abstract][Full Text] [Related]
7. [Regulation of receptor activator of nuclear factor kappaB ligand and osteoprotegerin expression by prostaglandin E2 in osteoblastic-like cells]. Wang BL; Zheng F; Qiu MC Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1992-6. PubMed ID: 19062743 [TBL] [Abstract][Full Text] [Related]
8. Zebrafish scales respond differently to in vitro dynamic and static acceleration: analysis of interaction between osteoblasts and osteoclasts. Kitamura K; Takahira K; Inari M; Satoh Y; Hayakawa K; Tabuchi Y; Ogai K; Nishiuchi T; Kondo T; Mikuni-Takagaki Y; Chen W; Hattori A; Suzuki N Comp Biochem Physiol A Mol Integr Physiol; 2013 Sep; 166(1):74-80. PubMed ID: 23632157 [TBL] [Abstract][Full Text] [Related]
9. Osteoclast inhibitory lectin (OCIL) inhibits osteoblast differentiation and function in vitro. Nakamura A; Ly C; Cipetić M; Sims NA; Vieusseux J; Kartsogiannis V; Bouralexis S; Saleh H; Zhou H; Price JT; Martin TJ; Ng KW; Gillespie MT; Quinn JM Bone; 2007 Feb; 40(2):305-15. PubMed ID: 17049328 [TBL] [Abstract][Full Text] [Related]
10. Expression of RANKL/OPG during bone remodeling in vivo. Tanaka H; Mine T; Ogasa H; Taguchi T; Liang CT Biochem Biophys Res Commun; 2011 Aug; 411(4):690-4. PubMed ID: 21771583 [TBL] [Abstract][Full Text] [Related]
11. The suppressive effect of myeloid Elf-1-like factor (MEF) in osteogenic differentiation. Kim YJ; Kim BG; Lee SJ; Lee HK; Lee SH; Ryoo HM; Cho JY J Cell Physiol; 2007 Apr; 211(1):253-60. PubMed ID: 17167770 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts. Rifas L; Arackal S; Weitzmann MN J Cell Biochem; 2003 Mar; 88(4):650-9. PubMed ID: 12577299 [TBL] [Abstract][Full Text] [Related]
13. Bradykinin potentiates cytokine-induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expression. Brechter AB; Lerner UH Arthritis Rheum; 2007 Mar; 56(3):910-23. PubMed ID: 17328065 [TBL] [Abstract][Full Text] [Related]
14. Induction of alkaline phosphatase activity by L-ascorbic acid in human osteoblastic cells: a potential role for CK2 and Ikaros. Son E; Do H; Joo HM; Pyo S Nutrition; 2007 Oct; 23(10):745-53. PubMed ID: 17664058 [TBL] [Abstract][Full Text] [Related]
15. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes. Shalhoub V; Conlon D; Tassinari M; Quinn C; Partridge N; Stein GS; Lian JB J Cell Biochem; 1992 Dec; 50(4):425-40. PubMed ID: 1469073 [TBL] [Abstract][Full Text] [Related]
16. Development of the osteoblast phenotype in primary human osteoblasts in culture: comparison with rat calvarial cells in osteoblast differentiation. Siggelkow H; Rebenstorff K; Kurre W; Niedhart C; Engel I; Schulz H; Atkinson MJ; Hüfner M J Cell Biochem; 1999 Oct; 75(1):22-35. PubMed ID: 10462701 [TBL] [Abstract][Full Text] [Related]
17. Functional alpha1- and beta2-adrenergic receptors in human osteoblasts. Huang HH; Brennan TC; Muir MM; Mason RS J Cell Physiol; 2009 Jul; 220(1):267-75. PubMed ID: 19334040 [TBL] [Abstract][Full Text] [Related]
18. Circulating mesenchymal stem cells with abnormal osteogenic differentiation in patients with osteoporosis. Dalle Carbonare L; Valenti MT; Zanatta M; Donatelli L; Lo Cascio V Arthritis Rheum; 2009 Nov; 60(11):3356-65. PubMed ID: 19877060 [TBL] [Abstract][Full Text] [Related]
19. RNA interference of the BMPR-IB gene blocks BMP-2-induced osteogenic gene expression in human bone cells. Singhatanadgit W; Salih V; Olsen I Cell Biol Int; 2008 Nov; 32(11):1362-70. PubMed ID: 18773965 [TBL] [Abstract][Full Text] [Related]
20. Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization. Brandao-Burch A; Utting JC; Orriss IR; Arnett TR Calcif Tissue Int; 2005 Sep; 77(3):167-74. PubMed ID: 16075362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]